FRT
53
7
PCAR
23
-4
HON
62
10
DHI
29
2
ED
45
2
PNC
64
5
LOW
30
-9
AMP
46
3
XRX
32
-2
V
30
-2
MO
53
2
O
42
-8
WMB
62
4
SO
66
2
ICE
57
-3
WM
60
-4
LEN
17
-6
FIS
58
-2
KO
39
-13
EXPE
58
2
FRT
53
7
PCAR
23
-4
HON
62
10
DHI
29
2
ED
45
2
PNC
64
5
LOW
30
-9
AMP
46
3
XRX
32
-2
V
30
-2
MO
53
2
O
42
-8
WMB
62
4
SO
66
2
ICE
57
-3
WM
60
-4
LEN
17
-6
FIS
58
-2
KO
39
-13
EXPE
58
2
Financhill
Back

Apellis Pharmaceuticals Vs. Regencell Bioscience Holdings Industry Stock Comparison

Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
$17.70
Seasonality Move:
-9.52%
Sell
37

RGC
Regencell Bioscience Holdings

Last Price:
$38.00
Seasonality Move:
-12.26%
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $17.69. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Regencell Bioscience Holdings (RGC) is a Sell

Is Regencell Bioscience Holdings a Buy, Sell or Hold?

  • The current Regencell Bioscience Holdings [RGC] share price is $38.01. The Score for RGC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • RGC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $17.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

RGC Stock Price Chart

What is Regencell Bioscience Holdings's stock price today?

  • The Regencell Bioscience Holdings share price today is $38.01
    The current trend is moderately bullish and RGC is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 42.98 Sell
Chaikin Money Flow: -561522 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.2 - 19.06) Sell
Bollinger Bands (100): (17.72 - 26.54) Sell

RGC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.9 Buy
Relative Strength Index (14 RSI): 56.71 Buy
Chaikin Money Flow: -1237079 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.58 - 39.9) Buy
Bollinger Bands (100): (-6.36 - 19.32) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.56 Sell
20-day SMA: 18.3 Sell
50-day SMA: 18.27 Sell
200-day SMA: 26.83 Sell
8-day EMA: 18.25 Sell
20-day EMA: 18.36 Sell
50-day EMA: 19.23 Sell
200-day EMA: 26.97 Sell

RGC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.96 Buy
20-day SMA: 25.15 Buy
50-day SMA: 12.58 Buy
200-day SMA: 3.31 Buy
8-day EMA: 42.13 Sell
20-day EMA: 29.22 Buy
50-day EMA: 17.26 Buy
200-day EMA: 5.81 Buy

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.

Regencell Bioscience Holdings Earnings Growth & RGC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regencell Bioscience Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):